Pediatric Autologous Bone Marrow Mononuclear Cells for Severe Traumatic Brain Injury

PHASE2CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

September 16, 2020

Study Completion Date

October 12, 2020

Conditions
Traumatic Brain Injury
Interventions
BIOLOGICAL

autologous bone marrow mononuclear cells

BMMNC infusion of either 6x10\^6 cells/kg or 10x10\^6 cells/kg weight.

OTHER

Placebo Infusion

Placebo infusion of 0.9% Sodium Chloride

Trial Locations (2)

77030

The University of Texas Health Science Center at Houston, Houston

85006

Phoenix Children's Hospital I University of Arizona, Phoenix

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

The University of Texas Health Science Center, Houston

OTHER

NCT01851083 - Pediatric Autologous Bone Marrow Mononuclear Cells for Severe Traumatic Brain Injury | Biotech Hunter | Biotech Hunter